Balance Sheet Croda International Plc

Equities

CRDA

GB00BJFFLV09

Specialty Chemicals

Market Closed - London S.E. Other stock markets 16:35:15 22/04/2026 BST			5-day change	1st Jan Change
3,001.00 ^GBX	+0.10%		+1.87%	+11.35%

04-22	FTSE 100 edges up on mixed signals from Iran	AN
04-22	Croda backs full-year targets as first-quarter sales edge lower	AN

f84a6189501c5.DHbDwTgtrgOzinpfben2zE-2kX9vfrm5wW1rBLF2g3I.bUCGs3IUyGie7yUtG5GZpjeb50dbF8_giiMBSdcD4EVVHfOkDgDtN__nQg

Published financial data: CRODA INTERNATIONAL PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.89B	2.09B	1.69B	1.63B	1.7B
Total Revenues	1.89B	2.09B	1.69B	1.63B	1.7B
Cost of Goods Sold, Total	951M	1.1B	964M	894M	954M
Gross Profit	939M	986M	730M	734M	746M
Selling General & Admin Expenses, Total	500M	538M	477M	502M	629M
Other Operating Expenses, Total	500M	538M	477M	502M	629M
Operating Income	439M	447M	253M	232M	116M
Interest Expense, Total	-22.1M	-24.1M	-26M	-31M	-28.3M
Interest And Investment Income	1.5M	2.7M	9.4M	6.9M	3M
Net Interest Expenses	-20.6M	-21.4M	-16.6M	-24.1M	-25.3M
Other Non Operating Income (Expenses)	-2.5M	-	-	-	-
EBT, Excl. Unusual Items	416M	426M	236M	208M	91M
Merger & Related Restructuring Charges	-1.5M	-	-	-	-
Gain (Loss) On Sale Of Assets	-	356M	-	-	-
Other Unusual Items	-3.3M	-1.7M	-	-	-
EBT, Incl. Unusual Items	412M	780M	236M	208M	91M
Income Tax Expense	88.7M	127M	64.2M	48.2M	26.3M
Earnings From Continuing Operations	323M	653M	172M	160M	64.7M
Net Income to Company	323M	653M	172M	160M	64.7M
Minority Interest	-2M	-4M	-1.1M	-1.1M	-2.7M
Net Income - (IS)	321M	649M	171M	158M	62M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	321M	649M	171M	158M	62M
Net Income to Common Excl. Extra Items	321M	649M	171M	158M	62M
Per Share Items
Net EPS - Basic	2.3	4.66	1.22	1.14	0.44
Basic EPS - Continuing Operations	2.3	4.66	1.22	1.14	0.44
Basic Weighted Average Shares Outstanding	140M	139M	140M	140M	140M
Net EPS - Diluted	2.3	4.65	1.22	1.14	0.44
Diluted EPS - Continuing Operations	2.3	4.65	1.22	1.14	0.44
Diluted Weighted Average Shares Outstanding	140M	140M	140M	140M	140M
Normalized Basic EPS	1.85	1.88	1.05	0.92	0.39
Normalized Diluted EPS	1.85	1.88	1.05	0.92	0.39
Dividend Per Share	1	1.08	1.09	1.1	1.11
Payout Ratio	41.3	22.24	88.13	96.03	249.84
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	537M	550M	360M	347M	234M
EBITA	474M	482M	290M	270M	153M
EBIT	439M	447M	253M	232M	116M
EBITDAR	538M	551M	361M	349M	236M
Effective Tax Rate - (Ratio)	21.56	16.24	27.17	23.2	28.9
Current Domestic Taxes	11.5M	28.1M	-1.5M	-800K	1.8M
Current Foreign Taxes	95M	100M	62.1M	62M	55.2M
Total Current Taxes	106M	128M	60.6M	61.2M	57M
Total Deferred Taxes	-17.8M	-1.4M	3.6M	-13M	-30.7M
Normalized Net Income	258M	262M	147M	129M	54.18M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	19.9M	19.9M	22.8M	28.6M	26.8M
Non-Cash Pension Expense	13.5M	9.3M	3.9M	4.8M	-2.5M
Supplemental Operating Expense Items
Selling and Marketing Expenses	93M	102M	77.2M	79.2M	80.7M
General and Administrative Expenses	406M	-	405M	427M	555M
Research And Development Expense From Footnotes	74.5M	81.8M	80.3M	81.4M	76.2M
Net Rental Expense, Total	1.4M	1M	1.2M	1.2M	1.3M
Imputed Operating Lease Interest Expense	269K	248K	376K	422K	422K
Imputed Operating Lease Depreciation	1.13M	752K	824K	778K	878K
Stock-Based Comp., Other (Total)	41.3M	-11M	-4.2M	5M	5M
Total Stock-Based Compensation	41.3M	-11M	-4.2M	5M	5M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	113M	321M	172M	167M	173M
Total Cash And Short Term Investments	113M	321M	172M	167M	173M
Accounts Receivable, Total	277M	315M	318M	277M	295M
Other Receivables	45.9M	47.1M	65.8M	57.5M	54.9M
Total Receivables	323M	362M	384M	334M	350M
Inventory	443M	464M	341M	368M	370M
Prepaid Expenses	14.6M	14.1M	11.9M	15.1M	13.5M
Total Current Assets	894M	1.16B	909M	884M	907M
Gross Property Plant And Equipment	1.7B	1.56B	1.68B	1.77B	1.99B
Accumulated Depreciation	-624M	-500M	-544M	-599M	-938M
Net Property Plant And Equipment	1.08B	1.06B	1.13B	1.17B	1.05B
Long-term Investments	3.3M	3.4M	1.9M	1.9M	1.9M
Goodwill	852M	845M	938M	900M	918M
Other Intangibles, Total	420M	409M	471M	411M	366M
Deferred Tax Assets Long-Term	13.5M	10.3M	14.4M	14.7M	31M
Other Long-Term Assets, Total	35.3M	123M	114M	130M	138M
Total Assets	3.29B	3.61B	3.58B	3.51B	3.41B
Liabilities
Accounts Payable, Total	133M	121M	126M	127M	130M
Accrued Expenses, Total	132M	131M	80.9M	102M	105M
Short-term Borrowings	18.5M	39M	22.3M	25.1M	4.2M
Current Portion of Long-Term Debt	32.4M	82.9M	14.4M	9.9M	144M
Current Portion of Leases	12.2M	12.9M	13.7M	13.2M	14.5M
Current Income Taxes Payable	49M	43.8M	21.4M	20.8M	17.9M
Other Current Liabilities	82.1M	56.9M	41.7M	38.3M	40.9M
Total Current Liabilities	460M	488M	320M	336M	457M
Long-Term Debt	795M	402M	588M	580M	470M
Long-Term Leases	78.3M	79.2M	71.3M	70.7M	63.7M
Pension & Other Post Retirement Benefits	27.4M	23.1M	26.8M	25.7M	23.4M
Deferred Tax Liability Non Current	151M	173M	193M	181M	164M
Other Non Current Liabilities	15.9M	16M	11.6M	18.4M	30.4M
Total Liabilities	1.53B	1.18B	1.21B	1.21B	1.21B
Preferred Stock Non Redeemable	1.1M	-	-	-	-
Total Preferred Equity	1.1M	-	-	-	-
Common Stock, Total	15.1M	15.1M	15.1M	15.1M	15.1M
Additional Paid In Capital	708M	708M	708M	708M	708M
Retained Earnings	1.07B	1.65B	1.64B	1.66B	1.57B
Comprehensive Income and Other	-43.8M	47.1M	-10.3M	-100M	-103M
Total Common Equity	1.75B	2.42B	2.35B	2.28B	2.19B
Minority Interest	12.8M	15.5M	15.6M	14.4M	15M
Total Equity	1.77B	2.43B	2.37B	2.3B	2.2B
Total Liabilities And Equity	3.29B	3.61B	3.58B	3.51B	3.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	140M	140M	140M	140M	139M
ECS Total Common Shares Outstanding	140M	140M	140M	140M	139M
Book Value / Share	12.56	17.3	16.85	16.35	15.69
Tangible Book Value	480M	1.16B	944M	972M	903M
Tangible Book Value Per Share	3.44	8.32	6.76	6.96	6.48
Total Debt	936M	616M	710M	699M	697M
Net Debt	823M	295M	538M	532M	524M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-21.4M	-111M	-99.8M	-116M	-125M
Debt Equivalent Oper. Leases	11.2M	8M	9.6M	9.6M	10.4M
Minority Interest, Total (Incl. Fin. Div)	12.8M	15.5M	15.6M	14.4M	15M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	122M	136M	98.3M	88.6M	93.7M
Inventories - Work In Process, Total	56M	45.8M	35.6M	44.9M	47.9M
Inventories - Finished Goods, Total	265M	282M	207M	234M	229M
Land - (BS)	297M	305M	320M	343M	431M
Machinery, Total	1.28B	1.12B	1.22B	1.28B	1.41B
Full Time Employees	6.14K	5.82K	5.85K	6.03K	5.95K
Accumulated Allowance for Doubtful Accounts (Supple)	2.9M	5.8M	6.8M	6.6M	8.2M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	321M	649M	171M	158M	62M
Depreciation & Amortization - CF	76.3M	83.4M	85.2M	93.5M	95.5M
Amortization of Goodwill and Intangible Assets - (CF)	34.3M	34.6M	37.4M	38.2M	36.8M
Depreciation & Amortization, Total	111M	118M	123M	132M	132M
Amortization of Deferred Charges, Total - (CF)	2.7M	2.7M	3.6M	4.1M	4.7M
(Gain) Loss From Sale Of Asset	5.8M	200K	200K	600K	-
(Gain) Loss on Sale of Investments - (CF)	-	-	1.5M	-	-
Asset Writedown & Restructuring Costs	1.1M	42.2M	22M	-	107M
(Income) Loss On Equity Investments - (CF)	700K	-	-	-	-
Stock-Based Compensation (CF)	29.1M	-11M	-4.2M	5M	5M
Other Operating Activities, Total	-20.6M	-359M	-8.3M	-1.4M	-17.1M
Change In Accounts Receivable	-53.2M	-43.3M	-19M	21.3M	-16.6M
Change In Inventories	-141M	-98.1M	118M	-39.3M	-7.3M
Change In Accounts Payable	91.6M	7.6M	-69.7M	38.9M	16.2M
Cash from Operations	348M	308M	338M	319M	286M
Capital Expenditure	-153M	-141M	-180M	-178M	-118M
Sale of Property, Plant, and Equipment	200K	1.7M	4M	900K	300K
Cash Acquisitions	-58.1M	-	-204M	-	-
Divestitures	-	584M	-	-	-
Sale (Purchase) of Intangible assets	-5.7M	-11.2M	-8.6M	-3.4M	-2.2M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	400K	-8.3M	-20.5M	41.8M	12.8M
Cash from Investing	-216M	425M	-410M	-139M	-107M
Long-Term Debt Issued, Total	320M	233M	336M	440M	182M
Total Debt Issued	320M	233M	336M	440M	182M
Long-Term Debt Repaid, Total	-297M	-632M	-228M	-467M	-171M
Total Debt Repaid	-297M	-632M	-228M	-467M	-171M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-2.4M	-7.3M	-9.8M	-1.8M	-7.3M
Common Dividends Paid	-132M	-144M	-151M	-152M	-155M
Preferred Dividends Paid	-100K	-	-	-	-
Common & Preferred Stock Dividends Paid	-132M	-144M	-151M	-152M	-155M
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-900K	-1.4M	-	-2.1M	-1.6M
Cash from Financing	-113M	-552M	-52.4M	-183M	-153M
Foreign Exchange Rate Adjustments	-2.4M	6.8M	-6.7M	-6.2M	-200K
Net Change in Cash	16.5M	187M	-131M	-8.5M	26.9M
Supplemental Items
Cash Interest Paid	19.8M	23.2M	24.2M	28.5M	25.3M
Cash Income Tax Paid (Refund)	112M	131M	69.3M	55.9M	55.8M
Levered Free Cash Flow	180M	119M	94.51M	123M	65.9M
Unlevered Free Cash Flow	193M	134M	111M	142M	83.59M
Change In Net Working Capital	77.2M	103M	-19.7M	-38M	11.2M
Net Debt Issued / Repaid	23.2M	-399M	108M	-26.5M	11.2M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.69	8.09	4.4	4.09	2.1
Return on Total Capital	10.55	9.72	5.16	4.77	2.47
Return On Equity %	19.21	31.13	7.17	6.84	2.88
Return on Common Equity	19.23	31.16	7.17	6.84	2.77
Margin Analysis
Gross Profit Margin %	49.69	47.17	43.08	45.08	43.88
SG&A Margin	26.43	25.77	28.16	30.83	37.04
EBITDA Margin %	28.41	26.34	21.25	21.34	13.8
EBITA Margin %	25.07	23.06	17.13	16.59	9.01
EBIT Margin %	23.25	21.4	14.92	14.24	6.84
Income From Continuing Operations Margin %	17.08	31.27	10.16	9.8	3.81
Net Income Margin %	16.98	31.08	10.09	9.74	3.65
Net Avail. For Common Margin %	16.98	31.08	10.09	9.74	3.65
Normalized Net Income Margin	13.66	12.54	8.65	7.91	3.19
Levered Free Cash Flow Margin	9.5	5.69	5.58	7.53	3.88
Unlevered Free Cash Flow Margin	10.23	6.42	6.54	8.72	4.92
Asset Turnover
Asset Turnover	0.6	0.61	0.47	0.46	0.49
Fixed Assets Turnover	1.84	1.95	1.55	1.42	1.53
Receivables Turnover (Average Receivables)	7.33	7.06	5.36	5.47	5.94
Inventory Turnover (Average Inventory)	2.55	2.43	2.4	2.52	2.58
Short Term Liquidity
Current Ratio	1.94	2.38	2.84	2.63	1.99
Quick Ratio	0.95	1.4	1.74	1.49	1.15
Operating Cash Flow to Current Liabilities	0.76	0.63	1.05	0.95	0.63
Days Sales Outstanding (Average Receivables)	49.83	51.71	68.13	66.87	61.46
Days Outstanding Inventory (Average Inventory)	143.13	149.97	152.36	145.12	141.3
Average Days Payable Outstanding	38.64	41.23	53.49	50.18	49.01
Cash Conversion Cycle (Average Days)	154.32	160.45	167	161.81	153.75
Long Term Solvency
Total Debt/Equity	53	25.33	29.99	30.44	31.63
Total Debt / Total Capital	34.64	20.21	23.07	23.33	24.03
LT Debt/Equity	49.43	19.79	27.86	28.34	24.25
Long-Term Debt / Total Capital	32.31	15.79	21.43	21.73	18.42
Total Liabilities / Total Assets	46.38	32.69	33.84	34.55	35.44
EBIT / Interest Expense	19.88	18.55	9.73	7.48	4.11
EBITDA / Interest Expense	24.89	23.45	14.44	11.73	8.78
(EBITDA - Capex) / Interest Expense	17.96	17.59	7.5	5.97	4.63
Total Debt / EBITDA	1.7	1.09	1.89	1.92	2.8
Net Debt / EBITDA	1.5	0.52	1.43	1.46	2.11
Total Debt / (EBITDA - Capex)	2.36	1.45	3.64	3.77	5.32
Net Debt / (EBITDA - Capex)	2.07	0.7	2.76	2.87	4
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	35.91	10.57	-18.9	-3.92	4.38
Gross Profit, 1 Yr. Growth %	48.54	4.97	-25.93	0.53	1.61
EBITDA, 1 Yr. Growth %	45.2	2.8	-34.58	-3.5	-32.5
EBITA, 1 Yr. Growth %	50.76	2.01	-39.73	-6.96	-43.32
EBIT, 1 Yr. Growth %	46.22	2.1	-43.44	-8.3	-49.85
Earnings From Cont. Operations, 1 Yr. Growth %	60.12	102.39	-73.66	-7.26	-59.46
Net Income, 1 Yr. Growth %	59.13	102.4	-73.66	-7.31	-60.88
Normalized Net Income, 1 Yr. Growth %	46.13	1.87	-44.06	-12.15	-57.93
Diluted EPS Before Extra, 1 Yr. Growth %	48.26	102.53	-73.69	-7.2	-60.88
Accounts Receivable, 1 Yr. Growth %	16.31	13.41	1.08	-12.92	6.68
Inventory, 1 Yr. Growth %	46.4	4.74	-26.47	7.83	0.71
Net Property, Plant and Equip., 1 Yr. Growth %	9.7	-1.36	6.6	3.22	-10.17
Total Assets, 1 Yr. Growth %	8.73	9.67	-0.91	-1.95	-2.8
Tangible Book Value, 1 Yr. Growth %	75.97	141.96	-18.79	2.96	-7.1
Common Equity, 1 Yr. Growth %	10.56	37.88	-2.61	-2.98	-4.18
Cash From Operations, 1 Yr. Growth %	21.15	-11.36	9.51	-5.36	-10.3
Capital Expenditures, 1 Yr. Growth %	33.04	-7.71	27.76	-1.11	-34.02
Levered Free Cash Flow, 1 Yr. Growth %	62.79	-33.38	-20.56	29.68	-46.23
Unlevered Free Cash Flow, 1 Yr. Growth %	58.84	-30.33	-17.36	28.15	-41.11
Dividend Per Share, 1 Yr. Growth %	9.89	8	0.93	0.92	0.91
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.11	22.59	-5.3	-11.72	0.14
Gross Profit, 2 Yr. CAGR %	21.96	24.87	-11.82	-13.71	1.07
EBITDA, 2 Yr. CAGR %	19.55	22	-17.99	-20.55	-19.29
EBITA, 2 Yr. CAGR %	20.03	23.82	-21.59	-25.12	-27.38
EBIT, 2 Yr. CAGR %	17.2	21.98	-24	-27.98	-32.19
Earnings From Cont. Operations, 2 Yr. CAGR %	20.1	80.02	-26.98	-50.57	-38.69
Net Income, 2 Yr. CAGR %	19.7	79.46	-26.99	-50.59	-39.79
Normalized Net Income, 2 Yr. CAGR %	16.81	21.79	-24.51	-29.9	-39.21
Diluted EPS Before Extra, 2 Yr. CAGR %	15.38	73.28	-27	-50.58	-39.75
Accounts Receivable, 2 Yr. CAGR %	25.58	14.85	7.07	-6.18	-3.62
Inventory, 2 Yr. CAGR %	28.35	23.83	-12.24	-10.96	4.21
Net Property, Plant and Equip., 2 Yr. CAGR %	12.42	4.02	2.55	4.9	-3.71
Total Assets, 2 Yr. CAGR %	31.97	9.2	4.25	-1.43	-2.38
Tangible Book Value, 2 Yr. CAGR %	7.57	106.35	40.18	-8.56	-2.2
Common Equity, 2 Yr. CAGR %	42.69	23.46	15.88	-2.79	-3.58
Cash From Operations, 2 Yr. CAGR %	6.96	3.63	-1.48	1.8	-7.86
Capital Expenditures, 2 Yr. CAGR %	20.6	10.81	8.59	12.4	-19.23
Levered Free Cash Flow, 2 Yr. CAGR %	9.19	3.87	-27.25	1.5	-16.5
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.26	4.94	-24.12	2.9	-13.13
Dividend Per Share, 2 Yr. CAGR %	5.41	8.94	4.4	0.92	0.91
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.86	14.89	6.82	-4.84	-6.65
Gross Profit, 3 Yr. CAGR %	21.59	16.01	4.92	-7.88	-8.88
EBITDA, 3 Yr. CAGR %	11.69	13.58	-0.88	-13.42	-24.75
EBITA, 3 Yr. CAGR %	12	13.57	-2.6	-16.99	-31.76
EBIT, 3 Yr. CAGR %	9.91	11.81	-5.59	-19.1	-36.17
Earnings From Cont. Operations, 3 Yr. CAGR %	10.65	42.92	-5.14	-20.93	-53.73
Net Income, 3 Yr. CAGR %	10.39	42.6	-5.34	-20.94	-54.29
Normalized Net Income, 3 Yr. CAGR %	8.79	11.47	-6.04	-20.6	-40.87
Diluted EPS Before Extra, 3 Yr. CAGR %	7.49	39.18	-7.55	-20.92	-54.29
Accounts Receivable, 3 Yr. CAGR %	12.51	21.38	10.06	-0.06	-2.08
Inventory, 3 Yr. CAGR %	15.54	19.94	4.08	-6	-7.23
Net Property, Plant and Equip., 3 Yr. CAGR %	11.31	7.63	4.88	2.77	-0.39
Total Assets, 3 Yr. CAGR %	19.86	24.07	5.72	2.14	-1.89
Tangible Book Value, 3 Yr. CAGR %	-3.49	40.94	51.22	26.48	-8.08
Common Equity, 3 Yr. CAGR %	20.98	41.07	14.08	9.22	-3.26
Cash From Operations, 3 Yr. CAGR %	9.89	0.47	5.55	-2.79	-2.4
Capital Expenditures, 3 Yr. CAGR %	15.15	10.31	16.19	5.25	-5.89
Levered Free Cash Flow, 3 Yr. CAGR %	22.72	-7.55	-5.01	-11.79	-17.87
Unlevered Free Cash Flow, 3 Yr. CAGR %	22.83	-6.11	-3.09	-9.64	-14.56
Dividend Per Share, 3 Yr. CAGR %	3.91	6.27	6.2	3.23	0.92
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.73	8.76	4.09	3.4	4.1
Gross Profit, 5 Yr. CAGR %	16.1	13.76	6.93	3.06	3.36
EBITDA, 5 Yr. CAGR %	10.2	7.98	-1.35	-1.55	-8.7
EBITA, 5 Yr. CAGR %	10.6	8.06	-2.95	-3.86	-13.39
EBIT, 5 Yr. CAGR %	9.19	6.71	-5.23	-6.23	-17.29
Earnings From Cont. Operations, 5 Yr. CAGR %	10.31	22.51	-6.3	-6.54	-20.33
Net Income, 5 Yr. CAGR %	10.28	22.33	-6.44	-6.68	-21.01
Normalized Net Income, 5 Yr. CAGR %	8.54	5.86	-6.07	-7.41	-21.06
Diluted EPS Before Extra, 5 Yr. CAGR %	8.81	20.44	-7.92	-8.02	-22.1
Accounts Receivable, 5 Yr. CAGR %	11.59	13.03	10.3	9.5	4.37
Inventory, 5 Yr. CAGR %	13.45	12.41	3.51	6.47	4.13
Net Property, Plant and Equip., 5 Yr. CAGR %	12.46	9.19	7.72	6.53	1.35
Total Assets, 5 Yr. CAGR %	17.04	16.98	13.35	13.16	2.4
Tangible Book Value, 5 Yr. CAGR %	14.49	21.73	12.05	18.54	27.03
Common Equity, 5 Yr. CAGR %	23.92	24.08	18.91	21.54	6.66
Cash From Operations, 5 Yr. CAGR %	5.68	3.26	5.19	1	-0.03
Capital Expenditures, 5 Yr. CAGR %	8.07	-1.95	12.48	11.14	0.47
Levered Free Cash Flow, 5 Yr. CAGR %	9.17	6.7	-0.54	-4.03	-9.78
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.85	7.91	1.21	-2.6	-7.24
Dividend Per Share, 5 Yr. CAGR %	5.7	5.41	4.11	4.1	4.05